Os Therapies Completes $6 Million Series A Funding Round
04/20/21, 12:53 PM
Location
Money raised
$6 million
Round Type
series a
OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS) and other deadly cancers in kids and adults including ovarian, esophageal, endometrial and lung cancers, today announced the closing of a $6 million Series A round of funding.